CWA Asset Management Group, LLC
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1667134
NAPLES, FL
Position in AUPH
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,435,406
+$673,951 QoQ
Shares Held
202,440
+8.6% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#59
of 279 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CWA Asset Management Group, LLC holds $28,091,999 across 13 Biotechnology names. AUPH ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
83,249 | $9,437,106 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
19,619 | $4,727,590 | |
| 3 | EXEL |
Exelixis, Inc.
|
63,173 | $3,437,242 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
This page
|
202,440 | $3,435,406 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
|
134,994 | $2,294,898 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
61,273 | $2,230,949 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,623 | $1,012,005 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
10,500 | $821,835 |
All Filings in AUPH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,435,406 | 202,440 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,761,455 | 186,333 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,060,755 | 129,201 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,365,249 | 123,552 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $909,661 | 107,398 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $685,546 | 85,267 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $398,613 | 44,389 | Shares | Sole | 2025-01-06 | |
| No filing history on record for this holder in this stock. | ||||||